ozanezumab

Ligand id: 8254

Name: ozanezumab

References
1. Caroni P, Schwab ME. (1988)
Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter.
Neuron, 1 (1): 85-96. [PMID:3272156]
2. Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. (2000)
Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1.
Nature, 403 (6768): 434-9. [PMID:10667796]
3. Clegg SJ, Ellis JH, Germaschewski V, Hamblin PA, Kopsidas G, Mcadam R, Prinjha RK. (2007)
Immunoglobulins.
Patent number: US8362208. Assignee: Glaxo Group Ltd , Clegg SJ, Ellis JH, Germaschewski V, Hamblin PA, Kopsidas G, Mcadam R, Prinjha RK. Priority date: 16/12/2005. Publication date: 29/11/2007.
4. Jokic N, Gonzalez de Aguilar JL, Dimou L, Lin S, Fergani A, Ruegg MA, Schwab ME, Dupuis L, Loeffler JP. (2006)
The neurite outgrowth inhibitor Nogo-A promotes denervation in an amyotrophic lateral sclerosis model.
EMBO Rep., 7 (11): 1162-7. [PMID:17039253]
5. Schmidt ER, Pasterkamp RJ, van den Berg LH. (2009)
Axon guidance proteins: novel therapeutic targets for ALS?.
Prog. Neurobiol., 88 (4): 286-301. [PMID:19523502]
6. Schnell L, Schwab ME. (1990)
Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors.
Nature, 343 (6255): 269-72. [PMID:2300171]